| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Abdelhamid M Attia | |
| Shereen Abdelghaffar | |||
| P2860 | cites work | Mechanism by which metformin reduces glucose production in type 2 diabetes | Q22241286 |
| Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus | Q24244739 | ||
| Metformin monotherapy for type 2 diabetes mellitus | Q24246552 | ||
| The case of the misleading funnel plot | Q24676535 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials | Q27860735 | ||
| Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses | Q27860840 | ||
| Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
| Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group | Q29547282 | ||
| Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 | ||
| A risk-benefit assessment of metformin in type 2 diabetes mellitus | Q33678321 | ||
| Report of the expert committee on the diagnosis and classification of diabetes mellitus | Q34167177 | ||
| Metformin, the rebirth of a biguanide: mechanism of action and place in the prevention and treatment of insulin resistance | Q34312067 | ||
| Metformin and insulin: is there a role for combination therapy? | Q36853607 | ||
| Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach | Q38723548 | ||
| The insulin-sparing effect of metformin in insulin-treated diabetic patients | Q40927900 | ||
| Insulin resistance due to hyperglycaemia: an adaptation protecting insulin-sensitive tissues | Q41555595 | ||
| Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial | Q43843247 | ||
| The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients | Q44231029 | ||
| Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial | Q44262745 | ||
| Metformin in type 1 diabetes: is this a good or bad idea? | Q44418892 | ||
| Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity | Q44599557 | ||
| Safety issues on metformin use. | Q44666310 | ||
| Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes. | Q50866522 | ||
| Effects of puberty and diabetes on metabolism of insulin-sensitive fuels. | Q51595174 | ||
| Effects of metformin on haemorheology, lipid parameters and insulin resistance in insulin-dependent diabetic patients (IDDM) | Q54308203 | ||
| Investigating and Dealing with Publication and Other Biases | Q56527888 | ||
| A Coefficient of Agreement for Nominal Scales | Q57167717 | ||
| Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: Assessment by the artificial pancreas | Q58622947 | ||
| Studies on juvenile--type diabetes in children. Assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides | Q67398945 | ||
| Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes | Q70269318 | ||
| WHO Expert Committee on Diabetes Mellitus: second report | Q71510049 | ||
| Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research | Q72082832 | ||
| Lactic acidosis in patients with diabetes treated with metformin | Q74085124 | ||
| Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem? | Q77130371 | ||
| P921 | main subject | Insulin Therapy | Q2002370 |
| preproinsulin | Q7240673 | ||
| metformin | Q19484 | ||
| type-1 diabetes | Q124407 | ||
| teenager | Q1492760 | ||
| P577 | publication date | 2009-01-21 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents |
| Q35772825 | A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes |
| Q48302673 | A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin? |
| Q34395471 | Approach to the obese adolescent with new-onset diabetes |
| Q38005031 | Cardiovascular disease risk in young people with type 1 diabetes. |
| Q39683336 | Clinical, Psychosocial, and Demographic Factors Are Associated With Overweight and Obesity in Early Adolescent Girls With Type 1 Diabetes |
| Q46522590 | Combined therapy with metformin and insulin attenuates systemic and hepatic alterations in a model of high-fat diet-/streptozotocin-induced diabetes |
| Q37102846 | Do obese children with diabetic ketoacidosis have type 1 or type 2 diabetes? |
| Q91105571 | Double or hybrid diabetes: A systematic review on disease prevalence, characteristics and risk factors |
| Q34288242 | Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study |
| Q36715464 | Metformin: an old but still the best treatment for type 2 diabetes |
| Q24188271 | Mulberry therapy for type 2 diabetes mellitus |
| Q89185246 | Obesity and diabetes-Not only a simple link between two epidemics |
| Q64116116 | Pharmacologic adjunctive to insulin therapies in type 1 diabetes: The journey has just begun |
| Q52562630 | Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else? |
| Q33741865 | The Effect of Metformin as an Adjunct Therapy in Adolescents with Type 1 Diabetes |
| Q38835797 | The Effect of Metformin on Adolescents with Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| Q34091638 | The use of metformin in type 1 diabetes: a systematic review of efficacy |
| Q37848915 | Use of metformin in pediatric age. |
Search more.